• NeuBase Therapeutics, Inc. reported a net loss of around $25.4 million, or $0.93 per share for the fiscal year ended September 30, 2021, versus a year-ago net loss of around $17.4 million, or $0.89 per share. NeuBase Therapeutics shares gained 0.7% to $3.08 in the after-hours trading session.
• Aeterna Zentaris Inc. named Giuliano La Fratta as Chief Financial Officer. Aeterna Zentaris shares fell 0.5% to close at $0.4202 on Thursday.
• Ares Management Corporation said its subsidiary, Ares Holdings L.P., agreed to acquire AMP's PrivateMarketsCo Infrastructure Debt platform for $308 million. Ares Management shares gained 3% to settle at $81.36 on Thursday.
• Escalade, Incorporated appointed Walter P. Glazer, Jr. as Chief Executive Officer and President. Escalade shares rose 0.6% to close at $15.69 on Thursday.
• The Drugs Controller General of India has given Bharat Biotech’s Covaxin Emergency Use approval in the paediatric age group between 12 and 18 years. Ocugen, Inc. has the US rights to the Bharat Biotech’s vaccine candidate. Ocugen shares dropped 1.5% to $5.22 in after-hours trading.